INBS - Comprehensive Filing Intelligence

Q2 2026•10-Q•Filed Feb 12, 2026

5.0/10

Filing Health:CAUTION

Notable concerns that warrant closer review

Executive Summary

Revenue is growing due to new customer acquisition and increased re-order rates, signaling market traction.. Gross margins are improving, driven by operational efficiencies and a favorable product mix, but this is offset by rising operating expenses.. The company has a commitment of $381,204 for a clinical study with CenExel HRI.. Revenue increased significantly driven by new customers and re-order rates.

Top Concerns

!The company has a commitment of $381,204 for a clinical study with CenExel HRI.
!Going Concern / Inability to Fund Operations (high)
!Nasdaq Listing Compliance (high)

Top Positives

+Revenue is growing due to new customer acquisition and increased re-order rates, signaling market traction.
+Significant investments in sales, marketing, and R&D are increasing operating expenses, impacting profitability despite revenue growth.

Analysis Dimensions

Our 5-pass AI analysis examines this filing across multiple dimensions. Each dimension score is derived from direct analysis of SEC filing text.

Narrative Intelligence

5.0/10

Management tone is balanced with focus on operational efficiencies.

Full analysis includes: tone changes vs prior quarter, margin driver breakdown, forward guidance analysis, strategic priorities.

Accounting Quality

7.0/10

Earnings quality shows moderate accounting practices.

Full analysis includes: reserve and allowance changes, non-recurring item analysis, stock-based compensation impact, disclosure concerns.

Hidden Liabilities

Off-balance sheet risk is low.

Full analysis includes: cloud and purchase commitments, VIE/SPE exposure, covenant compliance status, refinancing risk assessment.

Risk Landscape

2.0/10

Overall risk profile shows going concern / inability to fund operations as primary concern.

Full analysis includes: 8 risk categories with severity, new vs escalated risks, management response assessment, risk trend analysis.

Segment Performance

6.0/10

Segment health analysis.

Full analysis includes: segment-by-segment revenue breakdown, geographic concentration risk, customer concentration analysis, segment margin trends.